Arrowstreet Capital, Limited Partnership Moderna, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $650,305 - $980,427	-5,552 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $62.4 Million - $116 Million	-493,089 Reduced 98.89%	5,552 $956,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $19 Million - $31 Million	84,041 Added 20.27%	498,641 $127 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $92 Million - $201 Million	414,600 New	414,600 $160 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $24.6 Million - $41.9 Million	-225,343 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $14.8 Million - $38.3 Million	225,343 New	225,343 $23.5 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.